Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Biomarkers 2014

Andreas Jeromin's Biography

Andreas Jeromin, President & Cso, Atlantic Biomarkers LLC

Andreas Jeromin, PhD, has established research programs in translational neuroscience in both industry and biotech for the last 15 years and co-authored more than 100 publications. He has also been elected a member of the Dana Alliance for Brain Initiatives. Andreas Jeromin has led biomarker qualification programs in diagnostics and therapeutics in acute neurological injury and neurodegeneration in roles with increased responsibilities. This included several drug development program from POC to a NINDS-supported phase III trial (Protect III). He also supports as member of the SABs or steering committee, several biomarker qualification efforts such as ADNI, the Coalition against Major Diseases (CAMD) directed by the Critical Path Institute (C-PATH), the Alzheimer's Association CSF QC and biomarker assay standardization initiatives in other CNS disorders, including MS (Accelerated Cure), ALS and PD. He is the founder and CSO of Atlantic Biomarkers, LLC, and joined Quanterix, Inc. as scientific and medical advisor in 2014.

Andreas Jeromin Image

CNS Biomarkers from Discovery to Clinical Diagnostics: Molecules, Matrices and Platforms

Tuesday, 8 July 2014 at 09:00

Add to Calendar ▼2014-07-08 09:00:002014-07-08 10:00:00Europe/LondonCNS Biomarkers from Discovery to Clinical Diagnostics: Molecules, Matrices and Platforms Biomarkers 2014 in Cambridge, UKCambridge,

The presentation will provide an update on the current status of developing CNS biomarkers as tools to support diagnostics and drug development with selected case studies from Alzheimer's Disease and cerebrospinal fluid (CSF) biomarkers. 

Add to Calendar ▼2014-07-08 00:00:002014-07-09 00:00:00Europe/LondonBiomarkers 2014Biomarkers 2014 in Cambridge, UKCambridge,